Drug Store News on Sunday caught up with Brian McNamara, region head of Europe and the Americas of the recently christened GSK Consumer Healthcare, representing the joint venture between GlaxoSmithKline and Novartis to talk about what a consolidating OTC market means for the industry, and how GSK will be coming to market.
The Tallahassee Democrat published an opinion column by National Association of Chain Drug Stores president and CEO Steve Anderson, emphasizing pharmacists’ unique position in helping to address complex prescription pain medication issues.
Is this the year that restrictions on the use of over-the-counter medicines in conjunction with a flexible savings account are lifted? If you consider the value proposition — the $102 billion saved each year by the use of OTC medicines — and that health care is moving toward a more value-based, outcomes-driven system, it would certainly seem so.
Five macro trends impacted sales of OTC medicines in 2014, Bob Sanders, EVP at IRI, shared with attendees of the Consumer Healthcare Products Association Annual Executive Conference in March. On the plus side, switch continues to drive considerable growth across OTC aisles — Rx-to-OTC accounted for 19% of OTC sales and 27% of growth in the past five years, and that trend is likely to continue, Sanders said
Less than 1% of all pharmaceutical reports to American Association of Poison Control Centers associated with homeopathic medicines, the American Association of Homeopathic Pharmacists told the Food and Drug Administration.
Taiwan-based drug development company Sunny Pharmtech and Vitruvias Therapeutics, a generic drug development company, on Tuesday announced that they will team up to co-develop a portfolio of generic drug products.